ResearcherNational Taiwan University HospitalNo recent work listed

Shang‐Hsuan Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5260-9585; OpenAlex author ID A5103108661. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of MSH6: A case report. Co-author DOI 10.3389/fimmu.2022.1077840 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bang‐Bin Chen · 1 shared paper, 2022 · strength 0.20
- Paper Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline … DOI 10.3389/fimmu.2022.1077840 ↗
Ting‐Chun Kuo · 1 shared paper, 2022 · strength 0.20
- Paper Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline … DOI 10.3389/fimmu.2022.1077840 ↗
Shih‐Hung Yang · 1 shared paper, 2022 · strength 0.20
- Paper Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline … DOI 10.3389/fimmu.2022.1077840 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.